Kakimoto Asako, Kawazoe Miki, Kurihara Kanako, Mishima Takayasu, Tsuboi Yoshio
Department of Neurology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of Neurology, Konishi Daiichi Hospital, Fukuoka, Japan.
Front Neurol. 2023 Apr 17;14:1149615. doi: 10.3389/fneur.2023.1149615. eCollection 2023.
Long-term levodopa treatment in patients with Parkinson's disease (PwPD) often causes motor fluctuations, which are known to affect their quality of life (QOL). These motor fluctuations may be accompanied by fluctuations in non-motor symptoms. There is no consensus on how non-motor fluctuations affect QOL.
This was a single-center, retrospective study and included 375 patients with Parkinson's disease (PwPD) who visited the neurology outpatient department of Fukuoka University Hospital between July 2015 and June 2018. All patients were evaluated for age, sex, disease duration, body weight, and motor symptoms by the Movement Disorder Society-Unified Parkinson's Disease Rating Scale part III, depression scale by the Zung self-rating depression scale, apathy scale, and cognitive function by the Japanese version of The Montreal Cognitive Assessment. A nine-item wearing-off questionnaire (WOQ-9) was used to assess the motor and non-motor fluctuations. QOL in PwPD was investigated using the eight-item Parkinson's Disease Questionnaire (PDQ-8).
In total, 375 PwPD were enrolled and classified into three groups according to the presence or absence of motor and non-motor fluctuations. The first group included 98 (26.1%) patients with non-motor fluctuations (NFL group), the second group included 128 (34.1%) patients who presented with only motor fluctuations (MFL group), and the third group included 149 (39.7%) patients without fluctuations in motor or non-motor symptoms (NoFL group). Among them, the PDQ-8 SUM and SI were significantly higher in the NFL group than in the other groups ( < 0.005), implying that the NFL group had the poorest QOL among groups. Next, multivariable analysis showed that even one non-motor fluctuation was an independent factor that worsened QOL ( < 0.001).
This study showed that PwPD with non-motor fluctuation had a lower QOL than those with no or only motor fluctuation. Moreover, the data showed that PDQ-8 scores were significantly reduced even with only one non-motor fluctuation.
帕金森病(PwPD)患者长期使用左旋多巴治疗常导致运动波动,已知这会影响他们的生活质量(QOL)。这些运动波动可能伴有非运动症状的波动。关于非运动波动如何影响生活质量尚无共识。
这是一项单中心回顾性研究,纳入了2015年7月至2018年6月期间在福冈大学医院神经内科门诊就诊的375例帕金森病患者。所有患者均通过运动障碍协会统一帕金森病评定量表第三部分评估年龄、性别、病程、体重和运动症状,通过zung自评抑郁量表评估抑郁量表、淡漠量表,并通过日语版蒙特利尔认知评估评估认知功能。使用九项剂末现象问卷(WOQ-9)评估运动和非运动波动。使用八项帕金森病问卷(PDQ-8)调查PwPD的生活质量。
共纳入375例PwPD,并根据运动和非运动波动的有无分为三组。第一组包括98例(26.1%)有非运动波动的患者(NFL组),第二组包括128例(34.1%)仅出现运动波动的患者(MFL组),第三组包括149例(39.7%)运动和非运动症状均无波动的患者(NoFL组)。其中,NFL组的PDQ-8总和及单项得分均显著高于其他组(<0.005),这意味着NFL组在各组中生活质量最差。接下来,多变量分析表明,即使只有一次非运动波动也是生活质量恶化的独立因素(<0.001)。
本研究表明,有非运动波动的PwPD患者的生活质量低于无波动或仅有运动波动的患者。此外,数据显示,即使只有一次非运动波动,PDQ-8评分也会显著降低。